AstraZeneca

AstraZeneca/Merck’s Lynparza combination recommended by NICE for advanced ovarian cancer PMLiVE07:28
These 3 stocks are Cowen’s best ideas for 2024 including AstraZeneca and Datadog TipRanks05:25
AstraZeneca, Diageo, Lloyds & other UK Banks: What London's brokers had to say today Proactive Investors (US)10:48
AstraZeneca sues sun to block copies of three diabetes drugs Bloomberg Law15:56
AstraZeneca and Novo Nordisk among the top picks of this top US bank - here's why Proactive Investors (US)11:15
AbelZeta and AstraZeneca enter CAR-T cell therapy development deal Pharmaceutical Technology03:27
LianBio rejects Concentra bid; Treadwell cuts workers; AstraZeneca inks CAR-T deal ENDPOINTS10:08

Latest News

In the last 4 hours

AstraZeneca Just Joined the AI Drug Development Craze, but Is It a Buy in 2024? The Motley Fool08:53

In the last 6 hours

Is Now the Right Time to Buy AstraZeneca Stock? The Motley Fool07:21

Yesterday

AstraZeneca turns to AI for cancer antibody research CoinGeek23:03 9-Dec-23

In the last 7 days

AstraZeneca/Merck’s Lynparza combination recommended by NICE for advanced ovarian cancer PMLiVE07:28 8-Dec-23

AbelZeta and AstraZeneca enter CAR-T cell therapy development deal Pharmaceutical Technology03:27 8-Dec-23

Global Tyrosine Kinase Inhibitors Market Report 2023-2028, Featuring Profiles of Major Players… PR Newswire (Press Release)14:15 7-Dec-23

LianBio rejects Concentra bid; Treadwell cuts workers; AstraZeneca inks CAR-T deal ENDPOINTS10:08 7-Dec-23

AbelZeta Pharma Announces Agreement with AstraZeneca to Co-Develop a novel Glypican 3 (GPC3)… PR Newswire (Press Release)08:04 7-Dec-23

The Oxford Colloquy – New podcast series by Prof Sir Andrew Pollard University of Oxford04:27 7-Dec-23

Validation Data on a Novel Prognostic Test Developed by GRAIL in Stage I Lung Cancer Presented… Business Wire (Press Release)16:03 6-Dec-23

AstraZeneca, Absci sign $247M agreement to uncover AI-driven cancer drug candidates MobiHealthNews15:07 6-Dec-23

AstraZeneca, Diageo, Lloyds & other UK Banks: What London's brokers had to say today Proactive Investors (US)10:48 6-Dec-23

AstraZeneca Likes What Chinese Innovation Has To Offer Scrip Pharma Intelligence10:33 6-Dec-23

Metastatic Prostate Cancer Market to Grow Significantly by 2032 | AstraZeneca, Arvinas, Madison … Industry Today08:27 6-Dec-23

AstraZeneca and the world according to GARP Proactive Investors (US)08:16 6-Dec-23

Matan Companies Signs 198,000 SF Full-Building Lease with AstraZeneca at 700 Progress Way in… PRWeb (Press Release)08:04 6-Dec-23

Koselugo now available in Malaysia for paediatric patients with symptomatic neurofibromatosis type 1 (NF1) plexiform… AsiaOne05:06 6-Dec-23

Zibotentan by AstraZeneca for Microvascular Angina: Likelihood of Approval Pharmaceutical Technology21:48 5-Dec-23

AstraZeneca Sues Sun to Block Copies of Three Diabetes Drugs Bloomberg Law15:56 5-Dec-23

AstraZeneca says CMS guidance around IRA exemptions is 'unlawful' in latest court brief ENDPOINTS13:54 5-Dec-23

AZD-9592 by AstraZeneca for Non-Small Cell Lung Carcinoma: Likelihood of Approval Pharmaceutical Technology12:58 5-Dec-23

Absci and AstraZeneca Collaborate on AI-Driven Oncology Candidate PharmTech.com11:37 5-Dec-23

AstraZeneca and Novo Nordisk among the top picks of this top US bank - here's why Proactive Investors (US)11:15 5-Dec-23

Absci (ABSI) Up on AstraZeneca Deal to Design New Cancer Therapy Zacks07:37 5-Dec-23

AstraZeneca and generative AI company Absci enter $247m oncology partnership PMLiVE07:35 5-Dec-23

These 3 stocks are Cowen’s best ideas for 2024 including AstraZeneca and Datadog TipRanks05:25 5-Dec-23

Translational Science Is the Key to the Success of the Clinical Research PR Newswire (Press Release)04:00 5-Dec-23

AZD-9592 by AstraZeneca for Recurrent Head And Neck Squamous Cell Carcinoma: Likelihood of… Pharmaceutical Technology00:43 5-Dec-23

AZD-9592 by AstraZeneca for Metastatic Colorectal Cancer: Likelihood of Approval Pharmaceutical Technology00:43 5-Dec-23

AZD-7503 by AstraZeneca for Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD):… Pharmaceutical Technology00:33 5-Dec-23

AZD-7503 by AstraZeneca for Metabolic Dysfunction-Associated Steatohepatitis (MASH): Likelihood … Pharmaceutical Technology00:33 5-Dec-23

Dapagliflozin propanediol by AstraZeneca for Diastolic Heart Failure (HFpEF): Likelihood of… Pharmaceutical Technology20:37 4-Dec-23

AstraZeneca Criticizes HHS For Bid To Skirt Drug Price Suit Law36019:54 4-Dec-23

AstraZeneca bets $247m AI can create a cancer-fighting antibody The Register17:43 4-Dec-23

AstraZeneca Joins Forces with AI Biologics Firm Absci in Cancer Research Endeavor ETHNews.com16:58 4-Dec-23

Boris Johnson angrily accused Emmanuel Macron of trying to create controversy around the… Mail Online16:47 4-Dec-23

AstraZeneca commits $71 million to Meghalaya's forestry project Deccan Herald13:20 4-Dec-23

AstraZeneca commits $71 m to Meghalaya’s forestry project ThePrint12:52 4-Dec-23

Drug major AstraZeneca commits $71 mn to Meghalaya's forestry project The Business Standard12:18 4-Dec-23

Exciting opportunity to potentially design new antibody therapy with Absci and AsraZeneca… Outsourcing-Pharma.com11:00 4-Dec-23

AstraZeneca to Spend $247M in Collaboration with AI Discovery Outfit Absci BioSpace10:57 4-Dec-23

AstraZeneca to build CGT center in Hong Kong BioProcess Insider10:39 4-Dec-23

Absci Shares Rise 27% After Announcing Collaboration With AstraZeneca MarketWatch10:20 4-Dec-23

Signal: Absci and AstraZeneca sign deal on AI-powered cancer antibody drug Pharmaceutical Technology10:06 4-Dec-23

Millions of life-saving Covid jabs offered as thank you to Britain were turned down The Mirror09:41 4-Dec-23

AstraZeneca ends two Phase III trials due to enrollment issues Investing.com08:36 4-Dec-23

Absci, AstraZeneca Join To Deliver AI-designed Antibody Against Oncology Target RTT News08:16 4-Dec-23

Absci Announces Collaboration with AstraZeneca to Advance AI-Driven Oncology Candidate GlobeNewswire (Press Release)07:35 4-Dec-23

AstraZeneca inks $247M deal with generative AI shop Absci to develop antibody drug for cancer ENDPOINTS07:01 4-Dec-23

AstraZeneca inks $247M, AI-enabled oncology antibody design pact, joining Absci’s list of… FierceBiotech06:33 4-Dec-23

AstraZeneca to halt Phase III hyperkalaemia trials of Lokelma Clinical Trials Arena06:02 4-Dec-23

AstraZeneca partners with AI company to find cure for cancer Cointelegraph04:43 4-Dec-23

Boris Johnson allegedly planned military raid on Dutch Covid-19 vaccine factory NL Times04:41 4-Dec-23

AstraZeneca links with Absci on AI for biologics discovery pharmaphorum03:44 4-Dec-23

AstraZeneca, Absci Forge $247 Million Generative AI Partnership to Develop Cancer Treatment Metaverse Post03:25 4-Dec-23

Forxiga’s generic makers in Korea face advertising suspension Korea Biomedical Review01:34 4-Dec-23

Leveraging AI: AstraZeneca Joins Forces with Absci for Cancer Treatment TipRanks00:55 4-Dec-23

Revealed: How Boris Johnson asked spies to plan a raid on a Dutch Covid vaccine factory after… Mail Online17:11 3-Dec-23

5 things about AI you may have missed today: Doctors for free in a decade, tech giants fund Congressional AI fellows Hindustan Times11:50 3-Dec-23

AstraZeneca inks $247M AI partnership with Absci for cancer antibody TRT World05:22 3-Dec-23

AstraZeneca, AI biologics firm Absci tie up on cancer drug Deccan Herald01:58 3-Dec-23

AstraZeneca, AI biologics firm Absci tie up on cancer drug - FT Reuters01:36 3-Dec-23

In the last month

Explore spectacular new interactive mosaic artwork at AstraZeneca’s Discovery Centre in Cambridge – made of 1,000 images Cambridge Independent08:14 2-Dec-23

#COP28: AstraZeneca's AZ Forest initiative: Pledging six million trees in Kenya bizcommunity.com05:43 2-Dec-23

Crucial plans mapped out to decarbonise healthcare and manufacturing in China, India, UAE edie.net05:00 2-Dec-23

GSK, AstraZeneca, Johnson & Johnson and others raided in Turkish labour market probe Global Competition Review11:31 1-Dec-23

AstraZeneca Axes Two Phase III Hyperkalemia Trials for Lokelma BioSpace10:42 1-Dec-23

AstraZeneca (AZN) to Discontinue Two Studies on Lokelma Zacks10:37 1-Dec-23

AstraZeneca calls it quits on pair of trials for hyperkalemia drug it scored in buyout of ZS… FiercePharma10:01 1-Dec-23

Fierce Pharma Asia—AstraZeneca's KRAS bet; BeiGene's cancer deal; Coherus' PD-1 price FiercePharma08:41 1-Dec-23

AstraZeneca halts Phase III trials for kidney disease treatment Investing.com07:49 1-Dec-23

AstraZeneca To Discontinue STABILIZE-CKD, DIALIZE-Outcomes Trials Of Lokelma RTT News06:54 1-Dec-23

AstraZeneca halts two PhIII hyperkalemia studies intended to spotlight Lokelma’s clinical value ENDPOINTS06:38 1-Dec-23

AZ drops two trials aimed at expanding Lokelma’s label pharmaphorum05:32 1-Dec-23

AstraZeneca calls off two phase III trials into hyperkalaemia treatment London South East04:03 1-Dec-23

AstraZeneca discontinues two phase III evidence trials for Lokelma London South East03:42 1-Dec-23

AstraZeneca’s durvalumab recommended for bile duct cancers Pharmaceutical Technology03:38 1-Dec-23

AstraZeneca discontinues phase III trials Proactive Investors (UK)03:12 1-Dec-23

Live business live: Abu Dhabi group buys London property developer; Domino's Pizza firm faces ‘opportunistic’ takeover; … This is Money03:02 1-Dec-23

AstraZeneca continues to be among best places to work in Vietnam VnExpress International03:00 1-Dec-23

AstraZeneca to scrap two trials on drug that curbs potassium Reuters02:58 1-Dec-23

AstraZeneca To Discontine STABILIZE-CKD, DIALIZE-Outcomes Trials Under CRYSTALIZE Programme RTT News02:40 1-Dec-23

Update on CRYSTALIZE evidence trials AstraZeneca (Press Release)02:07 1-Dec-23

AstraZeneca Korea appoints Chon Se-whan as Country President Korea Biomedical Review00:24 1-Dec-23

Artificial Intelligence (AI) to optimise AstraZeneca’s reforestation programme in Africa African Press Organization00:00 1-Dec-23

AstraZeneca, University of Cambridge Expand Functional Genomics Collaboration Genetic Engineering and Biotechnology News15:20 30-Nov-23

Presage Biosciences Announces New Pharma Partnership to Evaluate Novel Immuno-Oncology Drug… PR Newswire (Press Release)08:01 30-Nov-23

Cardiovascular Drugs Market: A Deep Value Opportunity| Pfizer, AstraZeneca, Gilead Sciences Industry Today06:36 30-Nov-23

Class 3 Medicines Recall: AstraZeneca UK Ltd., Fluenz Tetra nasal spray suspension, EL(23)A/39 GOV.UK (Press Release)05:11 30-Nov-23

TRUQAP™ (capivasertib) Now Available from Onco360 Business Wire (Press Release)15:02 29-Nov-23

If I had to buy just one FTSE 100 stock in 2024, it would be this Motley Fool (UK)09:08 29-Nov-23

Milner Therapeutics to establish new genomics laboratory for drug discovery PharmaTimes07:57 29-Nov-23

AstraZeneca advances scientific leadership in hematology at ASH 2023 Business Wire (Press Release)07:04 29-Nov-23

AstraZeneca advances scientific leadership in haematology at ASH 2023 AstraZeneca (Press Release)02:08 29-Nov-23

Global Healthcare Leaders Advance Sector Decarbonisation Ahead of COP28 Business Wire (Press Release)02:00 29-Nov-23

Triple-Negative Breast Cancer Market to Grow Rapidly During the Forecast Period (2023–2032), Predicts DelveInsight |… GlobeNewswire (Press Release)13:05 28-Nov-23

White House urges RSV vaccine makers to meet demand Yahoo! US10:48 28-Nov-23

AstraZeneca succeeds in striking out suit over Covid-19 vaccine effects The Sun Daily09:23 28-Nov-23

AstraZeneca succeeds in striking out suit by 12 Malaysians over Covid-19 vaccine effects Malay Mail09:11 28-Nov-23

Milner, AstraZeneca, and MRC partner for functional genomics advancements UK BioIndustry Association07:33 28-Nov-23

R&D plans by drug giant AstraZeneca shot in arm for Hong Kong’s biomedical hub bid South China Morning Post19:16 27-Nov-23

AstraZeneca's KRAS deal with Yusen Jianheng; Abeona gets a PDUFA date ENDPOINTS11:28 27-Nov-23

Industry Comparison: Evaluating AstraZeneca Against Competitors In Pharmaceuticals Industry Benzinga11:24 27-Nov-23

BP, Entain, AstraZeneca and more: what brokers said today Proactive Investors (UK)10:31 27-Nov-23

AstraZeneca needs margin clarity for further upside, says Jefferies Proactive Investors (UK)10:00 27-Nov-23

AstraZeneca's rare disease unit receives NICE recommendation for Wolman disease therapy in infants PMLiVE07:27 27-Nov-23

AstraZeneca pays $24M to join race for next big KRAS opportunity, bagging Chinese rival to… FierceBiotech06:27 27-Nov-23

Barclays updates FTSE stock targets, AstraZeneca and Admiral rise Investing.com06:02 27-Nov-23

'I'm now a vaccine statistic! My back pain over the last week was in fact masking...a blood… Mail Online16:52 24-Nov-23

Aussie actor battling for AstraZeneca compensation after 'one-in-a-million' jab-related stroke 9News15:11 24-Nov-23

AstraZeneca, Novo Nordisk: anti-obesity drugs to lift compan... IG08:26 24-Nov-23

AstraZeneca Denies COVID Vaccine Defective After Clot Claim Law36008:25 24-Nov-23

Drug giant AstraZeneca to open Hong Kong R&D centre by late 2024 at earliest with focus on cell and gene therapies South China Morning Post07:50 24-Nov-23

Drug giant AstraZeneca to open Hong Kong R&D centre by late 2024 at earliest South China Morning Post07:44 24-Nov-23

AstraZeneca gains rights to Usynova’s KRAS inhibitor in deal worth almost $420m PMLiVE07:42 24-Nov-23

view more headlines

10 Dec 08:53

About our AstraZeneca news

Latest news on AstraZeneca, an Anglo-Swedish multinational pharmaceutical and biotechnology company based in Cambridge, with live updates on products and research.

AstraZeneca

Latest News

About our AstraZeneca news

Pharmaceuticals Top Stories

Business Top Stories